# Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction

> **NCT02451774** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ramón Óscar González-Ramella, Ph.D** · enrollment: 44 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Pentoxifylline Plus Chemotherapy
- **DRUG:** Placebo Plus Chemotherapy

## Key facts

- **NCT ID:** NCT02451774
- **Lead sponsor:** Ramón Óscar González-Ramella, Ph.D
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2018-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02451774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02451774, "Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02451774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*